The last day of the trading week gives an enormous chance to Midatech to gain significant points by reaching $3.00 as short term investors seek penny stocks to try quick luck.
Oncological diseases require complex treatment by forcing biotech firms to spend billions on R&D. Hence, no wonder negative EPS is on the screen near the NASDAQ: MTP chart. However, this case is very normal for cash-burning companies that always need the financial injection.
On Thursday MTP needed deep inhale by losing 6.67% on 524,710 shares of daily volume. As time goes by Midatech might be volatile with uptrending stock that could reach the level of Danaher or Regeneron.
Finance and Entertainment Reporter
Richard is a bottle of wine – the older the sweeter. He has already found the sweetest hobby in writing entertainment and finance news for Own Snap. Readers get the updated posts regularly from him searching for real-time news.